JPH09285296A - Judgement of transformation state of bioactivity - Google Patents

Abstract

PROBLEM TO BE SOLVED: To judge the subject transformation state by analyzing a quantum intrinsic energy of bioactivity transformed from one state to another state to give a specific spectrum and in the expression state of a spectrum related to the spectrum. SOLUTION: A quantum intrinsic energy in a specific region of bioactivity 2 of a cell transformed from one state to another is irradiated from an irradiation part 4, its spectrum is detected by a detecting part 6 and the spectrum is analyzed by a processor part 8 to give a spectrum showing characteristics of the transformed bioactivity 2. Then bioactivity 10 of a cell, etc., as a target is irradiated with the quantum intrinsic energy by the irradiation part 4, its spectrum is detected by the detecting part 6 and the expression state of the spectrum is compared with the specific spectrum of the bioactivity 2 to judge the transformation state of the bioactivity 10 of the target.

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for determining a transformed state of a bioactivity, and more particularly to a method for determining a transformed state of a bioactivity capable of easily determining a transformed state of a bioactivity such as a cell.

[0002]

2. Description of the Related Art Organic substances (cells, bacteria, fungi, viruses, etc.) having life or life activity, or organisms (fish, plants, etc.) which are aggregates of these organic substances (hereinafter referred to as "bioactivity") Can transform from one state to another due to various effects. For example, bioactive normal cells may transform into malignant cells.

Such transformation depends on the constitution. That is, as a family, there are constitutions in which normal cells are easily transformed into malignant cells, and constitutions in which they are difficult to transform. Therefore,
If the transformation state of the cell can be determined, the carcinogenic tendency can be predicted and swiftly dealt with.

[0004]

However, in the current research on malignant cells, there is a tendency toward material-centered principles such as identification of morphology and structural substances, elucidation of the structure of genes, and so far satisfactory results have been obtained. Not not. The number of atoms and molecules that make up a cell is enormous. We wash out such an enormous number of substances and their <quantum state> from normal cells and malignant cells. It is almost impossible to structurally define. Even normal cells,
This is because the atoms and molecules that are the constituent elements should change depending on the type of organism, the number of organisms, the organs, the nutritional status, the habitat environment, etc.

For this reason, since it is difficult to identify malignant cells, it is difficult to determine whether or not the cells have been transformed into malignant cells, and there is an inconvenience that the carcinogenic tendency cannot be predicted and swiftly dealt with. .

The present invention identifies atoms and molecules, which are constituents of bioactivity such as malignant cells, including their quantum states, by spectral analysis, and utilizes the unique spectrum showing the obtained characteristics to target It is intended to determine the transformation state of bioactivity.

[0007]

Therefore, according to the present invention, the quantum characteristic energy in a specific region of a bioactivity transformed from one state to another state is spectrally analyzed to determine the characteristics of the transformed bioactivity. It is characterized by obtaining the specific spectrum shown and determining the transformation state of the bioactivity of interest by the expression state of the spectrum associated with this specific spectrum.

[0008]

BEST MODE FOR CARRYING OUT THE INVENTION The present invention determines what the structure of a bioactivity is by determining the transformation state of a target bioactivity by the expression state of a spectrum associated with a unique spectrum showing the characteristics of bioactivity. It is possible to easily determine the transformation state of bioactivity without specifying whether or not it is, and it is possible to predict a carcinogenic tendency, for example.

[0009]

An embodiment of the present invention will be described below with reference to the drawings. 1 to 4 show an embodiment of the present invention. In FIG. 3, 2 is a bioactivity such as a cell, 4 is an irradiation unit, 6 is a detection unit, and 8 is an arithmetic processing unit.
The bioactivity 2 such as cells is irradiated with quantum energy such as electromagnetic waves and sound waves by the irradiation unit 4. Detection unit 6
Detects the spectrum of bioactivity 2 and inputs it to the arithmetic processing unit 8.

The arithmetic processing unit 8 analyzes the spectrum of the quantum characteristic energy in the specific region of the bioactivity 2 transformed from one state to the other state, and transforms the detected spectrum of the specific region into the transformed biotechnology. Obtained as a unique spectrum showing the characteristics of activity 2. Next, as shown in FIG. 4, the arithmetic processing unit 8 irradiates the symmetric bioactivity 10 with quantum energy by the irradiation unit 4 and detects the spectrum by the detection unit 6 to show the characteristic of the bioactivity 2. The biotransformation state of the target bioactivity 10 is determined based on the expression state of the spectrum associated with the unique spectrum.

The spectrum analysis was carried out by using various bioactivities such as normal cells and malignant cells, blood, bacteria and viruses as samples in a specific region, for example, an ultraviolet ray to millimeter wave region. The unique spectrum of each sample was widely observed over the entire measurement area. In cells and bacteria, a large number of unique absorption spectra were obtained particularly in the vicinity of the wave number of 1250 cm ^{−1 in the} infrared region.

An example of bioactivity transformed from one state to another state is, for example, malignant cells in which normal cells are transformed into cancer or tumor. As a result of spectral analysis of the quantum eigenenergy in a specific region of this malignant cell, a unique spectrum that is not always found in normal cells but is always observed in malignant cells, that is, multiple spectra that are considered to be indicators of malignancy were obtained. . As an example,
The wave number 1261.
An absorption spectrum at 4 cm ^-1 was obtained.

[0013] Thus, by detecting and analyzing the spectrum in a specific region of bioactivity transformed from normal cells to malignant cells, the detected spectrum can be obtained as a unique spectrum showing the characteristics of the malignant cells. You can

According to the spectrum of the malignant cells thus obtained, it can be determined whether or not the normal cells are transformed into the malignant cells. That is, the bioactivity of interest is associated with a unique spectrum exhibiting this characteristic, for example, by expressing how a matching or approximate unique spectrum is expressed, the transformation state from normal cells to malignant cells can be determined. Can be determined.

By this method, blood was collected from the living body and the spectrum was detected. As a result, the wave number of 1261.4 cm, which is the unique spectrum of the malignant cells, from the blood of the cancer family.
A spectrum of ^-1 was obtained (see Figure 1). This unique spectrum of malignant cells does not appear in the blood of non-cancerous families. A spectrum with a wave number of 1245.9 cm ⁻¹ was obtained from the blood of a non-cancerous family as its unique spectrum (see FIG. 2).

That is, it is possible to determine whether a normal cell is a structure in which normal cells are easily transformed into malignant cells or a structure in which normal cells are not easily transformed, depending on whether or not a specific spectrum as an index of malignant cells appears. Probability can be predicted, and carcinogenic tendency can be predicted and swift response.

Further, according to this method, the substance or the state of the substance which is an index of the carcinogenic tendency of the living body can be easily detected qualitatively and quantitatively even if the substance cannot be specified as the substance.

Further, according to this method, the possibility of carcinogenesis of the insured person can be predicted, and therefore, the method can be applied to calculation of insurance charge when underwriting insurance.

In this embodiment, the absorption spectrum is exemplified as the peculiar spectrum, but the peculiar spectrum includes the divergence spectrum. That is, the quantum intrinsic energy of bioactivity is an electromagnetic wave,
It includes all sound waves, heat, and other quantum energies, and it can obtain the above-mentioned absorption spectrum and divergence spectrum as a unique spectrum by spectrally analyzing the absorbed energy and emitted energy of the quantum energy due to bioactivity. is there.

As described above, according to the present invention, it is possible to determine the transformation state of cells, bacteria, fungi, viruses and the like which are bioactivities, and to predict the possibility of transformation in various fields. it can.

Therefore, in the medical field, the present invention can be applied to prediction of carcinogenicity, diagnosis of malignant cells and evaluation of therapeutic effect, identification of malignant cells difficult to be evaluated pathologically, prediction of effect of anticancer drug, and the like. In addition to the above malignant cells, it can be applied to bacteria and viruses.

Further, not only in the field of medicine but also in the fields of agriculture, forestry, fisheries and livestock, it is possible to predict the possibility of suffering from diseases of animals and plants and to intentionally or intentionally improve varieties by the expression state of a unique spectrum. It can be applied.

[0023]

As described above, according to the present invention, the state of transformation of a target bioactivity or its possibility can be easily determined by spectra without specifying what its structure is. Can be determined.

Therefore, according to the present invention, the transformation state of bioactivity can be determined, and the possibility of transformation can be predicted, and the transformation can be predicted more quickly. .

[Brief description of drawings]

FIG. 1 is a diagram showing the spectrum of blood of a person of a cancer family.

FIG. 2 is a diagram showing the spectrum of blood of a non-cancer family member.

FIG. 3 is a block diagram of a system for carrying out the method of the present invention.

FIG. 4 is a configuration diagram of a system for explaining a transformation state of symmetrical bioactivity.

[Explanation of symbols]

 2 Bioactivity 4 Irradiation unit 6 Detection unit 8 Arithmetic processing unit 10 Bioactivity to be symmetrical

Front page continuation (71) Applicant 596069988 Go Watanabe 3 10-10 Nijinooka, Izumi-ku, Sendai-shi, Miyagi 703 Pacific Nijinooka 703 (71) Applicant 000118213 Hiromasa Ito 390-82, Aoba, Aramaki, Aoba-ku, Sendai-shi, Miyagi ( 71) Applicant 597049798 Kosuke Goto 1-10-6 Sagigamori, Aoba-ku, Sendai City, Miyagi Prefecture (72) Inventor Tomoya Sato 4-22 Miyamachi, Fukushima City, Fukushima Prefecture (72) Inventor Akira Masai Aizuwakamatsu, Fukushima Prefecture 3-8, Chuo, City Chuo Park, Lions Mansion, No. 806 (72) Nankai Kodama, 6-24 Hanazono, Fukushima City, Fukushima Prefecture (72) Takeshi Watanabe, 1-10 Nijinooka, Izumi-ku, Sendai City, Miyagi Prefecture 3 Pacific Rainbow Hill 703 (72) Inventor Hiromasa Ito 390-82 Aoba, Aramaki, Aoba-ku, Sendai City, Miyagi Prefecture

Claims (1)

[Claims] 1. A spectral analysis of quantum eigenenergy in a specific region of bioactivity transformed from one state to another state to obtain a unique spectrum showing the characteristic of the transformed bioactivity, A method for determining a transformation state of a bioactivity, which comprises determining a transformation state of a target bioactivity based on the expression state of the spectrum related to the spectrum.